Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution

About this update from Marinomed Biotech Ag

EQS Voting Rights Announcement: Marinomed Biotech AG Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution 29.06.2026 / 09:29 CET/CEST Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement.Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018  Klosterneuburg,  25.6.2026  Overview ☐Notification made after deadline Caution: In case of violations of major holdings notification rules, please pay attention to Section 137 BörseG 2018 (Suspension of voting rights)  1. Issuer: Marinomed Biotech AG2. Reason for the notification: Other3. Person subject to notification obligation Hermann Unger4. Name of shareholder(s): 5. Date on which the threshold was crossed or reached: 25.6.2026 6. Total positions    % of voting rights attached to shares (7.A) % of voting rights through financial/other instruments (7.B.1 + 7.B.2)  Total of both in % (7.A + 7.B)  Total number of voting rights of issuerResulting situation on the date on which threshold was crossed / reached   3,63 %   0,00 %   3,63 %   1 998 979Position of previous notification (if applicable)   6,40 %       6,40 %     Details7. Notified details of the resulting situation:  A: Voting rights attached to shares ISIN Code Number of voting rights % of voting rightsDirect (Sec 130 BörseG 2018) Indirect (Sec 133 BörseG 2018) Direct (Sec 130 BörseG 2018) Indirect (Sec 133 BörseG 2018)ATMARINOMED6 72 538   3,63 %  SUBTOTAL A 72 538 3,63 %   B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018 Type of instrument Expiration Date Exercise Period Number of voting rights that may be acquired if the instrument is exercised % of voting rights            SUBTOTAL B.1       B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018Type of instrument Expiration Date Exercise Period Physical / Cash Settlement Number of voting rights % of voting rights               SUBTOTAL B.2       8. Information in relation to the p...

View stock analysis, news, and events for Marinomed Biotech Ag